Immunosuppressive capacity of mesenchymal stem cells correlates with metabolic activity and can be enhanced by valproic acidMadeleine C. Killer, Cornelia Brendel, Miriam Frech et al.|Stem Cell Research & Therapy|2017Cited by 51
Immunosuppressive capabilities of mesenchymal stromal cells are maintained under hypoxic growth conditions and after gamma irradiationPhilipp Nold, Cornelia Brendel, Christian Fölsch et al.|Cytotherapy|2014Cited by 37
High β-1,4-Galactosyltransferase-I expression in peripheral T-lymphocytes is associated with a low risk of relapse in germ-cell cancer patients receiving high-dose chemotherapy with autologous stem cell reinfusionVerena Nilius‐Eliliwi, Cornelia Brendel, Madeleine C. Killer et al.|OncoImmunology|2018Cited by 11
Detection of minimal residual disease in circulating cell-free DNA in acute myeloid leukemiaCharlotte Sommer, Elisabeth Mack, Hildegard I. D. Mack et al.|Scientific Reports|2025Cited by 5
Genetic engineering of primary human mesenchymal stromal cells using the CRISPR/Cas9 synergistic activation mediatorMadeleine C. Killer, Cornelia Brendel, Xiaoqing Zhang et al.|Research Square|2025Cited by 0